All terms
Warning Letter
Formal FDA notification of significant violations requiring prompt corrective action.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
An FDA Warning Letter is a notice to a regulated entity citing significant violations and requesting prompt corrective action, typically within 15 business days. What the regulation says
The FDA issues Warning Letters to address violations of regulatory significance, as outlined in 21 CFR Part 820 for Quality System Regulation, 21 CFR Part 4 for combination products, and other applicable regulations like those found in 21 CFR Parts 801 and 809 for labeling and advertising. These letters serve as official communications indicating that the agency believes violations may lead to enforcement action if not promptly corrected. The FDA Field Management Directive (FMD) 140 provides guidance regarding the issuance and content of Warning Letters.What this means in practice
Warning Letters are public and can affect new submissions, imports, and reputation. Repeat or unresolved issues can lead to seizures or injunctions.Examples
- A medical device manufacturer receives a Warning Letter citing violations of 21 CFR 820.30, Quality System Design Controls, for inadequate design validation procedures related to a new product being marketed.
- A pharmaceutical company is issued a Warning Letter due to repeated observations of unsanitary conditions and manufacturing deficiencies, which violate 21 CFR 211, Current Good Manufacturing Practice for Finished Pharmaceuticals.
- An online retailer receives a Warning Letter for illegally marketing unapproved MedTech products with unsubstantiated claims, constituting a violation of the Federal Food, Drug, and Cosmetic Act.
Common pitfalls
- •Assuming a Warning Letter is merely a suggestion, rather than a formal communication of regulatory non-compliance that demands a response.
- •Failing to address all cited observations in the Warning Letter, which can lead to further enforcement actions.
- •Submitting a response without sufficient evidence or documentation of corrective actions.
- •Delaying the response past the specified timeframe, typically 15 business days, without prior communication and agreement with the FDA.
- •Underestimating the public and business impact of a Warning Letter, including potential effects on stock prices, contractual agreements, and reputation.
Frequently asked questions
An FDA Warning Letter serves to notify a regulated entity of significant deviations from regulatory requirements that, if not corrected, may result in enforcement actions. It is a formal communication demanding prompt corrective action.
Related terms
Shared paths + categoryQuality & Risk
FDA Form 483
Notice of inspectional observations issued at the conclusion of an FDA inspection.
QMS Foundations · adjacent
Quality & Risk
Quality System Regulation(QSR / 21 CFR 820)
FDA's current good manufacturing practice (cGMP) requirements for medical devices.
QMS Foundations
Quality & Risk
Complaint Handling
Process for receiving, evaluating, and responding to device complaints.
QMS Foundations
Quality & Risk
Corrective and Preventive Action(CAPA)
Systematic process to investigate and resolve quality issues and prevent recurrence.
QMS Foundations
Quality & Risk
Design Controls
Structured process governing the design of medical devices.
QMS Foundations
Quality & Risk
Design History File(DHF)
Compilation of records describing the design history of a finished device.
QMS Foundations
Latest in MedTech
Primary references
3 sourcesLink health: 3 verified· last checked 2026-06-20
FDA·2MDIC·1
- 1FDA Warning LettersVerifiedFDAfda.gov
- 2MDIC Case for QualityVerifiedMDICmdic.org
- 3FDA - Quality SystemsVerifiedFDAfda.gov
Inline markers like [1] jump to the matching reference above.